IIM
STLN

INTECH Investment Management’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

INTECH Investment Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69K Buy
22,482
+4,760
+27% +$14.6K ﹤0.01% 1964
2025
Q4 		$63.1K Sell
17,722
-1,887
-10% -$7K ﹤0.01% 2238
2025
Q3 		$68.4K Sell
19,609
-9,005
-31% -$30.9K ﹤0.01% 2338
2025
Q2 		$58.7K Buy
+28,614
New +$71.5K ﹤0.01% 2402

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

INTECH Investment Management's STLN Position: Q1 2026 in Review

INTECH Investment Management increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 27% in Q1 2026, buying an estimated $14.6K and bringing the position to 22,482 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

INTECH Investment Management first reported a position in STLN in Q2 2025 and has held it in 4 quarters since. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • INTECH Investment Management held 22,482 shares of Starling Oncology Institute, Inc. Common Stock worth $69K as of Q1 2026.
  • INTECH Investment Management bought 4,760 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $14.6K.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1964 holding.
  • INTECH Investment Management first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2025 and has held it in 4 quarters since.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.